Skip to content

About Us
Our Approach
Pipeline
- Overview
- Publications
Clinical Trials
Investors
Contact

About Us
Our Approach
Pipeline
- Overview
- Publications
Clinical Trials
Investors
Contact

PRESS RELEASES

Choose Year
Search Press Releases

Found 214 Results

May 28, 2015

Minerva Neurosciences to Present at Upcoming Investor Conferences in June

May 18, 2015

Minerva Neurosciences Announces Appointment of Dr. Fouzia Laghrissi-Thode to Its Board of Directors

May 7, 2015

Minerva Neurosciences Reports First Quarter 2015 Financial Results and Other Key Business Updates

April 30, 2015

Minerva Neurosciences to Host First Quarter 2015 Financial Results Webcast and Conference Call

March 26, 2015

Minerva Neurosciences Reports Fourth Quarter and Full Year 2014 Financial Results

March 19, 2015

Minerva Neurosciences to Host Fourth Quarter and Full Year 2014 Financial Results Webcast and Conference Call

March 18, 2015

Minerva Neurosciences Completes Private Placement, Raises $31 Million

March 13, 2015

Minerva Neurosciences Announces $31 Million Financing

January 21, 2015

Minerva Neurosciences Reports Positive Phase 1 Data With MIN-202, Selective Orexin-2 Antagonist for Treatment of Sleep Disorders Including Primary and Comorbid Insomnia

January 20, 2015

Minerva Neurosciences Announces $15 Million Debt Facility With Oxford Finance LLC and Silicon Valley Bank

«...18 192021 22

Investor Relations Contact

Corey Davis, Ph.D.
LifeSci Advisors, LLC
212-915-2577
cdavis@lifesciadvisors.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy^*

Unsubscribe

Loading...

Minerva Neurosciences, Inc.
1500 District Avenue
Burlington, MA 01803

Company

About Us
Leadership
Board of Directors
Contact

Science

Our Approach
Pipeline
Publications
Clinical Trials

Investors

Investors Overview
News
Events
SEC Filings
Stock Information
Corporate Governance
FAQs

© 2026 Minerva Neurosciences, Inc.

Privacy Policy
Terms of Use
Accessibility Statement
Cookie Policy

Scroll to Top